Found: 8
Select item for more details and to access through your institution.
Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 703, doi. 10.1007/s40264-023-01321-4
- By:
- Publication type:
- Article
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 689, doi. 10.1007/s40264-023-01314-3
- By:
- Publication type:
- Article
The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 619, doi. 10.1007/s40264-023-01313-4
- By:
- Publication type:
- Article
Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 677, doi. 10.1007/s40264-023-01312-5
- By:
- Publication type:
- Article
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 661, doi. 10.1007/s40264-023-01307-2
- By:
- Publication type:
- Article
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 625, doi. 10.1007/s40264-023-01302-7
- By:
- Publication type:
- Article
Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 647, doi. 10.1007/s40264-023-01296-2
- By:
- Publication type:
- Article
Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson's Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 637, doi. 10.1007/s40264-023-01288-2
- By:
- Publication type:
- Article